<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-14T11:40:09Z</responseDate>
  <request identifier="oai:figshare.com:article/33994806" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/33994806</identifier>
        <datestamp>2026-09-25T11:39:52Z</datestamp>
        <setSpec>category_694</setSpec>
        <setSpec>portal_316</setSpec>
        <setSpec>item_type_3</setSpec>
        <setSpec>month_year_09_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>Table 1_From chromatin to proteostasis: multilevel gene regulation in Mendelian diseases.docx</dc:title>
          <dc:creator>Himanshu Goel (509740)</dc:creator>
          <dc:creator>Gunjan Garg (17386294)</dc:creator>
          <dc:subject>Epigenetics (incl. Genome Methylation and Epigenomics)</dc:subject>
          <dc:subject>DNA methylation</dc:subject>
          <dc:subject>episignatures</dc:subject>
          <dc:subject>gene expression regulation</dc:subject>
          <dc:subject>Mendelian disease</dc:subject>
          <dc:subject>noncoding RNA</dc:subject>
          <dc:subject>proteostasis</dc:subject>
          <dc:subject>RNA splicing</dc:subject>
          <dc:subject>translational regulation</dc:subject>
          <dc:description>&lt;p&gt;Pathogenic variation can alter gene output at multiple levels, from chromatin accessibility and enhancer-promoter communication to RNA processing, translation and protein turnover. The diagnostic challenge is not to catalogue these layers, but to determine which regulatory mechanism is plausible for a given variant, phenotype, tissue and developmental context. This targeted narrative review synthesises representative Mendelian mechanisms across five linked levels: chromatin, transcription, RNA processing and stability, translation, and post-translational proteostasis. Three cross-cutting principles recur. First, distinct molecular lesions may converge on the same functional bottleneck: altered dosage, timing, localisation or disrupted protein homeostasis. Second, regulatory effects are often cell-type-, isoform-, developmental-stage- and state-specific, so assay and tissue selection are integral to interpretation. Third, a negative result in an accessible surrogate such as blood does not exclude a disease-relevant effect in brain, muscle, liver or stimulated immune cells. From these principles, the review derives a mechanism-directed diagnostic framework that links variant class to orthogonal assays, including DNA methylation profiling, chromatin and reporter assays, RNA sequencing, ribosome-level methods and protein-based studies. The framework is offered as an integrative clinical synthesis rather than a new model of gene regulation, to support variant interpretation, functional-test selection and translational prioritisation in unsolved Mendelian disease.&lt;/p&gt;</dc:description>
          <dc:date>2026-09-25T11:39:52Z</dc:date>
          <dc:type>Dataset</dc:type>
          <dc:type>Dataset</dc:type>
          <dc:identifier>10.3389/freae.2026.1944086.s001</dc:identifier>
          <dc:relation>https://figshare.com/articles/dataset/Table_1_From_chromatin_to_proteostasis_multilevel_gene_regulation_in_Mendelian_diseases_docx/33994806</dc:relation>
          <dc:rights>CC BY 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
